Skip to main content
Erschienen in: Journal of Endocrinological Investigation 6/2014

01.06.2014 | Opinion

Serum-negative autoimmune thyroiditis: what’s in a name?

verfasst von: M. Rotondi, F. Coperchini, F. Magri, L. Chiovato

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Excerpt

Chronic autoimmune thyroiditis (CAT) is the main cause of hypothyroidism in the general population. Autoantibodies to thyroperoxidase (TPO) and to thyroglobulin (Tg) are the circulating hallmark of this autoimmune thyroid disease. Positive tests for TPO Ab and Tg Ab are present in nearly 90 (TPOAb) and 60 % (Tg Ab) of hypothyroid patients with CAT. This implies that despite the high sensitivity of modern assay methods for thyroid auto Ab, there still is a considerable number of patients presenting with hypothyroidism in whom the humoral markers of thyroid autoimmunity are found to be negative. The widespread use of ultrasound in the diagnostic work-up of thyroid diseases allowed to ascertain that most of these patients display a hypoechoic pattern of the thyroid at ultrasound [1]. Further characterization of this echographic finding indicated that this peculiar echopattern is mainly due to lymphocytes infiltrating the thyroid parenchyma, as confirmed by fine needle aspiration biopsy. On this basis, a new clinical entity was identified, the so-called serum-negative chronic autoimmune thyroiditis (SN-CAT). …
Literatur
1.
Zurück zum Zitat Vitti P, Rago T (2003) Thyroid ultrasound as a predicator of thyroid disease. J Endocrinol Invest 26:686–689PubMedCrossRef Vitti P, Rago T (2003) Thyroid ultrasound as a predicator of thyroid disease. J Endocrinol Invest 26:686–689PubMedCrossRef
2.
Zurück zum Zitat Takamatsu J, Yoshida S, Yokozawa T, Hirai K, Kuma K, Ohsawa N, Hosoya T (1998) Correlation of antithyroglobulin and antithyroid-peroxidase antibody profiles with clinical and ultrasound characteristics of chronic thyroiditis. Thyroid 8:1101–1106PubMedCrossRef Takamatsu J, Yoshida S, Yokozawa T, Hirai K, Kuma K, Ohsawa N, Hosoya T (1998) Correlation of antithyroglobulin and antithyroid-peroxidase antibody profiles with clinical and ultrasound characteristics of chronic thyroiditis. Thyroid 8:1101–1106PubMedCrossRef
3.
Zurück zum Zitat Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P, Pinchera A (1993) Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77:1700–1705PubMed Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P, Pinchera A (1993) Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77:1700–1705PubMed
4.
Zurück zum Zitat Dussault JH, Letarte J, Guyda H, Laberge C (1980) Lack of influence of thyroid antibodies on thyroid function in the newborn infant and on a mass screening program for congenital hypothyroidism. J Pediatr 96:385–389PubMedCrossRef Dussault JH, Letarte J, Guyda H, Laberge C (1980) Lack of influence of thyroid antibodies on thyroid function in the newborn infant and on a mass screening program for congenital hypothyroidism. J Pediatr 96:385–389PubMedCrossRef
5.
Zurück zum Zitat Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P (2007) Role of chemokines in endocrine autoimmune diseases. Endocr Rev 28:492–520PubMedCrossRef Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P (2007) Role of chemokines in endocrine autoimmune diseases. Endocr Rev 28:492–520PubMedCrossRef
6.
Zurück zum Zitat Rago T, Chiovato L, Grasso L, Pinchera A, Vitti P (2001) Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dysfunction in apparently healthy subjects. J Endocrinol Invest 24:763–769PubMedCrossRef Rago T, Chiovato L, Grasso L, Pinchera A, Vitti P (2001) Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dysfunction in apparently healthy subjects. J Endocrinol Invest 24:763–769PubMedCrossRef
7.
Zurück zum Zitat Vejbjerg P, Knudsen N, Perrild H, Laurberg P, Pedersen IB, Rasmussen LB, Ovesen L, Jørgensen T (2006) The association between hypoechogenicity or irregular echo pattern at thyroid ultrasonography and thyroid function in the general population. Eur J Endocrinol 155:547–552PubMedCrossRef Vejbjerg P, Knudsen N, Perrild H, Laurberg P, Pedersen IB, Rasmussen LB, Ovesen L, Jørgensen T (2006) The association between hypoechogenicity or irregular echo pattern at thyroid ultrasonography and thyroid function in the general population. Eur J Endocrinol 155:547–552PubMedCrossRef
8.
Zurück zum Zitat Rotondi M, Magri F, Chiovato L (2011) Thyroid and obesity: not a one-way interaction. J Clin Endocrinol Metab 96:344–346PubMedCrossRef Rotondi M, Magri F, Chiovato L (2011) Thyroid and obesity: not a one-way interaction. J Clin Endocrinol Metab 96:344–346PubMedCrossRef
9.
Zurück zum Zitat Radetti G, Longhi S, Baiocchi M, Cassar W, Buzi F (2012) Changes in lifestyle improve body composition, thyroid function, and structure in obese children. J Endocrinol Invest 35:281–285PubMed Radetti G, Longhi S, Baiocchi M, Cassar W, Buzi F (2012) Changes in lifestyle improve body composition, thyroid function, and structure in obese children. J Endocrinol Invest 35:281–285PubMed
10.
Zurück zum Zitat Rotondi M, Cappelli C, Leporati P, Chytiris S, Zerbini F, Fonte R, Magri F, Castellano M, Chiovato L (2010) A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity. Eur J of Endocrinol 163:105–109CrossRef Rotondi M, Cappelli C, Leporati P, Chytiris S, Zerbini F, Fonte R, Magri F, Castellano M, Chiovato L (2010) A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity. Eur J of Endocrinol 163:105–109CrossRef
11.
Zurück zum Zitat Agretti P, De Marco G, Di Cosmo C, Bagattini B, Ferrarini E, Montanelli L, Vitti P, Tonacchera M (2014) Frequency and effect on serum TSH of phosphodiesterase 8B (PDE8B) gene polymorphisms in patients with sporadic nonautoimmune subclinical hypothyroidism. J Endocrinol Invest 37:189–194PubMedCrossRef Agretti P, De Marco G, Di Cosmo C, Bagattini B, Ferrarini E, Montanelli L, Vitti P, Tonacchera M (2014) Frequency and effect on serum TSH of phosphodiesterase 8B (PDE8B) gene polymorphisms in patients with sporadic nonautoimmune subclinical hypothyroidism. J Endocrinol Invest 37:189–194PubMedCrossRef
Metadaten
Titel
Serum-negative autoimmune thyroiditis: what’s in a name?
verfasst von
M. Rotondi
F. Coperchini
F. Magri
L. Chiovato
Publikationsdatum
01.06.2014
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 6/2014
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0083-8

Weitere Artikel der Ausgabe 6/2014

Journal of Endocrinological Investigation 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.